Madrigal Pharmaceuticals Ownership | Who Owns Madrigal Pharmaceuticals?

Overview Forecast RevenueFinancials Chart Transcripts

Madrigal Pharmaceuticals Ownership Summary

Madrigal Pharmaceuticals is owned by 105.67% institutional investors, 5.70% insiders. Baker bros. advisors lp is the largest institutional shareholder, holding 9.55% of MDGL shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.62% of its assets in Madrigal Pharmaceuticals shares.

MDGL Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Madrigal Pharmaceuticals	105.67%	5.70%	-11.37%
Sector	Healthcare Stocks	35.71%	11.88%	52.42%
Industry	Biotech Stocks	35.98%	11.86%	52.17%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Baker bros. advisors lp	2.14M	9.55%	$1.12B
Janus henderson group	2.02M	9.00%	$1.05B
Rtw investments, lp	1.99M	8.89%	$1.04B
Avoro capital advisors	1.82M	8.10%	$951.76M
Vanguard group	1.81M	8.05%	$1.05B
Blackrock	1.43M	7.14%	$399.86M
Blackrock funding, inc. /de	1.56M	6.95%	$816.59M
Paulson	1.39M	6.21%	$728.77M
Wellington management group llp	694.96K	3.10%	$363.79M
State street	609.52K	2.72%	$319.07M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Paulson	1.39M	23.42%	$728.77M
Rtw investments, lp	1.99M	10.38%	$1.04B
Avoro capital advisors	1.82M	9.36%	$951.76M
Tao capital management lp	21.00K	9.25%	$10.99M
Ally bridge group (ny)	32.66K	9.12%	$14.98M
Tri locum partners lp	67.71K	7.14%	$31.05M
Baker bros. advisors lp	2.14M	6.44%	$1.12B
Rock springs capital management lp	171.00K	5.28%	$89.51M
Iron triangle partners lp	58.38K	3.81%	$26.78M
Armistice capital	264.58K	2.46%	$138.50M

Top Buyers

Holder	Shares	% Assets	Change
Janus henderson group	2.02M	0.52%	433.80K
Citadel advisors	453.84K	0.04%	417.71K
Wellington management group llp	694.96K	0.07%	233.56K
Blackrock	1.43M	0.01%	216.86K
Norges bank	196.39K	0.01%	196.39K

Top Sellers

Holder	Shares	% Assets	Change
Holocene advisors, lp	-	-	-390.55K
Paulson	1.39M	23.42%	-315.33K
Ra capital management	-	-	-204.50K
Bain capital life sciences investors	-	-	-197.00K
Alkeon capital management	80.00K	0.07%	-160.00K

New Positions

Holder	Shares	% Assets	Change	Value
Norges bank	196.39K	0.01%	196.39K	$114.37M
Toronto dominion bank	130.46K	0.10%	130.46K	$68.29M
Vanguard fiduciary trust	128.08K	0.02%	128.08K	$67.05M
Westfield capital management co lp	94.81K	0.21%	94.81K	$49.63M
Logos global management lp	85.00K	2.22%	85.00K	$44.49M

Sold Out

Holder	Change
Marquette asset management	-1.00
Atlas capital advisors	-1.00
Sjs investment consulting	-1.00
True wealth design	-1.00
Td capital management	-1.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	400	-2.91%	23,705,222	0.58%	105	0.96%	194	-10.19%	126	5.88%
Dec 31, 2025	121	-68.24%	2,435,684	-89.59%	10	0.10%	55	-72.36%	40	-61.90%
Sep 30, 2025	135	-57.68%	3,008,956	-86.78%	13	0.13%	69	-51.75%	40	-63.64%
Jun 30, 2025	325	-4.69%	23,563,853	0.96%	106	0.95%	144	-20.00%	111	18.09%
Mar 31, 2025	341	6.90%	23,616,052	2.83%	106	0.96%	178	4.09%	96	26.32%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard US Total Market Shares ETF	578.31K	2.62%	388.00
Vanguard Total Stock Mkt Idx Inv	587.99K	2.55%	1.47K
Vanguard Health Care Inv	444.14K	1.93%	202.94K
Janus Concentrated Growth CF	429.42K	1.86%	-
Janus Henderson Forty S	429.42K	1.86%	-
Vanguard Small Cap Index	422.81K	1.83%	-935.00
iShares Russell 2000 ETF	402.28K	1.75%	3.38K
Janus Henderson Opportunistic Alpha MA	319.65K	1.47%	319.62K
SPDR® S&P Biotech ETF	299.46K	1.34%	670.00
Polar Capital Biotech S Inc	273.15K	1.18%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jun 01, 2026	Soergel David	Chief Medical Officer	Sell	$516.56K
May 22, 2026	Levy Richard S	-	Sell	$77.06K
May 22, 2026	Levy Richard S	-	Sell	$162.64K
May 22, 2026	Levy Richard S	-	Sell	$20.27K
May 22, 2026	Levy Richard S	-	Sell	$311.95K

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	-	14
2026 Q1	-	83
2025 Q4	-	70
2025 Q3	54	78
2025 Q2	-	-

MDGL Ownership FAQ

Who Owns Madrigal Pharmaceuticals?

Madrigal Pharmaceuticals shareholders are primarily institutional investors at 105.67%, followed by 5.70% insiders and -11.37% retail investors. The average institutional ownership in Madrigal Pharmaceuticals's industry, Biotech Stocks , is 35.98%, which Madrigal Pharmaceuticals exceeds.

Who owns the most shares of Madrigal Pharmaceuticals?

Madrigal Pharmaceuticals’s largest shareholders are Baker bros. advisors lp (2.14M shares, 9.55%), Janus henderson group (2.02M shares, 9.00%), and Rtw investments, lp (1.99M shares, 8.89%). Together, they hold 27.43% of Madrigal Pharmaceuticals’s total shares outstanding.

Does Blackrock own Madrigal Pharmaceuticals?

Yes, BlackRock owns 7.14% of Madrigal Pharmaceuticals, totaling 1.43M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 399.86M$. In the last quarter, BlackRock increased its holdings by 216.86K shares, a 17.92% change.

Who is Madrigal Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Paulson is Madrigal Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 23.42% of its assets in 1.39M Madrigal Pharmaceuticals shares, valued at 728.77M$.

Who is the top mutual fund holder of Madrigal Pharmaceuticals shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Madrigal Pharmaceuticals shares, with 2.62% of its total shares outstanding invested in 578.31K Madrigal Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools